Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure

Addiction Biology - Tập 13 Số 2 - Trang 253-263 - 2008
Miriam Schneider1
1Central Institute of Mental Health (ZI), Department of Psychopharmacology, Germany

Tóm tắt

ABSTRACT

During puberty, neuronal maturation of the brain, which began during perinatal development, is completed such that the behavioral potential of the adult organism can be fully achieved. These maturational events and processes of reorganization are needed for the occurrence of adult behavioral performance but simultaneously render the organism highly susceptible to perturbations, such as exposure to psychoactive drugs, during this critical developmental time span. Considering the variety of maturational processes occurring in the endocannabinoid system during this critical period, it is not surprising that the still‐developing brain might by highly susceptible to cannabis exposure. Emerging evidence from human studies and animal research demonstrates that an early onset of cannabis consumption might have lasting consequences on cognition, might increase the risk for neuropsychiatric disorders, promote further illegal drug intake and increase the likelihood of cannabis dependence. These findings suggest that young people represent a highly vulnerable cannabis consumer group and that they run a higher risk than adult consumers of suffering from adverse consequences from cannabinoid exposure. The aim of the present review is to provide an overview over the possible deleterious residual cannabinoid effects during critical periods of postnatal maturation and to offer a more precise delineation of the vulnerable time window for cannabinoid exposure.

Từ khóa


Tài liệu tham khảo

10.1002/1098-2396(200008)37:2<167::AID-SYN11>3.0.CO;2-B

10.1192/bjp.184.2.110

10.1016/S0376-8716(99)00150-7

10.1016/0892-0362(94)00053-G

10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R

10.1007/s00213-003-1550-7

10.1097/01.yco.0000218592.00689.e5

10.1176/appi.ajp.161.11.1967

10.1038/sj.npp.1300296

10.1016/j.biopsych.2005.01.026

10.1016/j.pbb.2006.03.006

10.1176/appi.ajp.160.6.1041

10.1016/j.drugalcdep.2004.11.014

Clegg E, 1960, The age at which male rats become fertile, J Reprod Fertil, 1, 119

10.1046/j.1360-0443.2002.00029.x

10.1192/bjp.182.4.330

10.1111/j.1369-1600.2007.00095.x

10.1046/j.1360-0443.2003.00437.x

10.1159/000058095

DeWit D, 1997, Patterns of onset and cessation of drug use over the early part of the life course, Health Educ Behav, 25, 746, 10.1177/109019819702400609

10.1016/S0920-9964(00)90371-2

10.1007/s002130050892

10.1016/j.ejphar.2004.06.048

10.1038/sj.npp.1301127

EMCDDA(2006)Report on European Drug Use. Available at:http://ar2006.emcdda.europa.eu/en/home‐en.html?CFID=6556355&CFTOKEN=775dc8d09f40f3c7‐C10A6570‐94C2‐5A43‐C5A9EED9672B4893&jsessionid=2e30aa2470a451721240(Internet Communication) Accessed 15 November 2007.

10.1203/00006450-200110000-00009

10.1111/j.1360-0443.2005.01322.x

10.1046/j.1360-0443.2000.9545053.x

10.1001/archpsyc.60.10.1033

10.1210/en.2004-1622

10.1016/S0166-2236(99)01491-5

10.1016/S0024-3205(99)00295-7

10.1016/0165-3806(96)00087-9

10.1210/en.2004-1672

10.1016/j.pbb.2005.01.032

10.1038/7268

10.1111/j.1476-5381.1978.tb07001.x

10.1111/j.1360-0443.2006.01427.x

10.1371/journal.pmed.0030039

10.1111/j.1440-1614.2006.01756.x

10.1046/j.1440-1614.2000.00685.x

10.1016/S0140-6736(98)05021-1

10.1016/j.tins.2007.06.006

10.1177/0269881103174007

10.1126/science.1188374

10.15288/jsa.1992.53.447

10.1111/j.1360-0443.2006.01426.x

10.1095/biolreprod17.2.298

10.1111/j.1369-1600.2008.00106.x

10.1093/oxfordjournals.aje.a009894

10.1007/s10519-005-9023-x

10.1111/j.1360-0443.2006.01428.x

10.1046/j.1460-9568.2003.02599.x

10.1016/0376-8716(94)90006-X

10.1037/0033-2909.93.3.441

10.1111/j.1360-0443.2005.01088.x

10.1016/0039-128X(91)90131-E

Ojeda SR, 1994, The Physiology of Reproduction, 363

10.1177/0269881106065188

10.1177/0269881104047277

10.2174/156800705774933014

10.1136/bmj.325.7374.1195

10.1111/j.1360-0443.2006.01728.x

10.1542/peds.2003-0626-F

10.1016/j.biopsych.2004.05.006

10.1016/S0376-8716(02)00334-4

10.1001/archpsyc.58.10.909

10.1111/j.1360-0443.2005.01033.x

10.1038/442865a

10.1038/sj.npp.1301475

10.1192/bjp.180.3.216

10.1016/0024-3205(94)00585-0

10.1126/science.276.5321.2050

10.1097/00001756-199302000-00005

10.1111/j.1365-2826.2003.01106.x

10.1016/S0165-3806(02)00306-1

SAMHSA, 2004, Substance Abuse and Mental Health Service Administration. Results from the 2003 National Survey on Drug Use and Health: National Findings

SchneiderM DrewsE KochM(2005)Behavioral effects in adult rats of chronic prepubertal treatment with the cannabinoid receptor agonist WIN 55.Behav Pharmacol212–212.

10.1038/sj.npp.1300225

10.1038/sj.npp.1300634

Schneider M, 2007, The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion, Eur Neuropsychopharmacol, 17, 180, 10.1016/j.euroneuro.2006.03.009

10.1007/s00213-006-0676-9

10.1038/nn1326

10.1016/S0920-9964(00)00132-8

10.1016/S0149-7634(00)00014-2

10.1002/dev.420160203

10.1016/j.ejphar.2003.08.101

10.1007/BF00431932

10.1007/BF00431933

Stiglick A, 1985, Residual effects of chronic cannabis treatment on behavior in mature rats, Psychopharmacology, 85, 436, 10.1007/BF00429660

10.1101/lm.7.3.132

10.1176/appi.ajp.161.3.501

10.1095/biolreprod39.3.540

10.1016/S0024-3205(01)01516-8

10.1300/J069v19n01_01